<?xml version="1.0" encoding="UTF-8"?>
<p class="p">Lysosomes contain the enzymatic tools for the degradation of extracellular molecules. The transcription factor EB (TFEB) partially controls lysosome biogenesis [
 <xref rid="B90-ijms-20-02167" ref-type="bibr" class="xref">90</xref>]. TFEB effect first enhances lysosomal exocytosis [
 <xref rid="B91-ijms-20-02167" ref-type="bibr" class="xref">91</xref>], second promotes the degradation of autophagic substrates and third helps the clearance of lipid droplets and of mitochondria [
 <xref rid="B92-ijms-20-02167" ref-type="bibr" class="xref">92</xref>,
 <xref rid="B93-ijms-20-02167" ref-type="bibr" class="xref">93</xref>,
 <xref rid="B94-ijms-20-02167" ref-type="bibr" class="xref">94</xref>]. Low amounts of cholesterol and high amounts of SL characterize the lysosomal lipid signature, indeed increased cholesterol levels in lysosomes are used as an early trait of numerous lysosomal storage diseases (LSDs) (reviewed in [
 <xref rid="B19-ijms-20-02167" ref-type="bibr" class="xref">19</xref>,
 <xref rid="B95-ijms-20-02167" ref-type="bibr" class="xref">95</xref>]).
</p>
